Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis — Stella

Home/Allergic Bronchopulmonary Aspergillosis (ABPA)/

View on ClinicalTrials.gov

Recruiting

Back to Allergic Bronchopulmonary Aspergillosis (ABPA) trials

Trial locations(1 site)

China

Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China, Jinan, Shandong

Key details

Sponsor

Qianfoshan Hospital

Collaborators

Shanghai Pulmonary Hospital, Tongji University School of Medicine, Fudan University

Enrollment target

~140 participants

Started

May 2025

Primary completion

July 2027

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.